Dr. Dobry is a Board-Certified, Child, Adolescent and Adult Psychiatrist whose clinical focus is on patients with treatment-resistant depression, bipolar spectrum disorders and other mood disorders.
Dr. Dobry’s father was a psychiatrist, and medicine was always in his future growing up. He was drawn to Psychiatry as a field in medicine with more room for flexibility in treatment, and an opportunity to dissect a narrative and uncover clinical facts to lead to a patient’s relief from suffering.
After years of practicing psychiatry, most recently as the Medical Director at the UCSF’s Pediatric Mood and Anxiety Disorders Program, Dr. Dobry sees a patient’s motivation and engagement as a crucial part of the treatment process. He builds trust with patients and believes the doctor/patient relationship plays an essential role in treatment success. He has experience helping more complex patients and adolescent patients and finding medical approaches to relieve their suffering.
Having led a mood disorders clinic in an academic institution that specialized in treating patients with depression and bipolar disorders, he is extremely interested in using Transcranial Magnetic Stimulation as part of his treatment regimen for treatment-resistant patients, as it adds another tool in dealing with a challenging psychopathology. With his strong experience in medication management and passion for helping depressed patients where traditional treatment paths have not been successful, he sees TMS as an opportunity to alleviate extremely taxing symptoms of depression, especially when used in conjunction with more classic pharmacologic treatments.
He joined TMS Health Solutions in the Spring of 2018.
Dr. Dobry loves the unparalleled nature and climate of the Bay Area, as well as the cultural and intellectual richness and diversity. Having lived in the San Francisco for much of his life, he appreciates the bigger city feel it offers, yet with nature and a different pace. He enjoys getting outdoors and hiking, getting out of the Bay Area and traveling, and getting immersed in a juicy historical book to learn more about the past and uncover the parallels between today and days long gone.
Dr. Dobry’s interest in the brain mind connection and human behavior began when he was pursuing his Bachelor’s degree from the University of California at Berkeley in Molecular and Cell Biology. He started working in a neuroscience research lab, where the principal investigator was a psychiatrist, with a goal of understanding the psychiatric pathology. One of his first projects involved investigating the genetic and molecular mechanism of psychiatric disorders, including depression.
He graduated from the Tel Aviv University School of Medicine, and then completed a general adult residency at the Mount Sinai School of Medicine in New York. He went on to a Child and Adolescent Psychiatry Fellowship at Stanford University Medical Center.
During training, schooling and residency, Dr. Dobry worked in a variety of both research and clinical positions. He was the sole attending Psychiatrist at a community clinic for the underserved population in Brooklyn, NY where he managed an ambulatory psychiatric clinic serving a large, clinically and socially complex population of patients. He also worked as an attending psychiatrist for an inpatient adult unit at a hospital. Throughout his training, he continued to sharpen both his research and clinical technique.
Dr. Dobry joined the University of California, San Francisco, in 2015. He was involved in the education of clinical child and adolescent psychiatry fellows, general psychiatry residents as well as medical students. At the UCSF, he continued co-leading number of clinical and research projects. Soon after joining UCSF, Dr. Dobry became Medical Director of the UCSF Pediatric Mood and Anxiety Disorders Program. In his role as the director, he was able to hone his clinical skills in psychiatric disorders and especially with mood disorders. He focused on treating the more complex patients and educating and mentoring residents on how to best treat patients with bipolar disorders and depression.
VGLUT2 Trafficking Is Differentially Regulated by Adaptor Proteins AP-1 and AP-3. Li H, Santos MS, Park CK, Dobry Y, Voglmaier SM. Front Cell Neurosci. 2017;26(11):324.
Li H, Santos MS, Park CK, Dobry Y, Voglmaier SM. VGLUT2 Trafficking Is Differentially Regulated by Adaptor Proteins AP-1 and AP-3. Front Cell Neurosci.2017; 11:324.
Dobry Y, Novakovic V, Barkin RL, Sundaram VK. Management of auditory hallucinations as a sequela of traumatic brain injury: a case report and a relevant literature review. Am J Ther. 2014; 21(1).
Soorya L, Kolevzon A, Zweifach J, Lim T, Dobry Y, Schwartz L, Frank Y, Wang AT, Cai G, Parkhomenko E, Halpern D, Grodberg D, Angarita B, Willner JP, Yang A, Canitano R, Chaplin W, Betancur C, Buxbaum JD. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Mol Autism. 2013; 4(1):18.
Rice T, Dobry Y, Wang E, Novakovic V, Sher L. Cognitive effects of quetiapine in a patient with dementia with Lewy bodies. Psychogeriatrics. 2013; 13(1):52-7.
Dobry Y, Rice T, Sher L. Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. Int J Adolesc Med Health. 2013; 25(3):193-9.
Dobry Y, Braquehais MD, Sher L. Bullying, psychiatric pathology and suicidal behavior. Int J Adolesc Med Health. 2013; 25(3):295-9.
Dobry Y, Sher L. The underexamined association between posttraumatic stress disorder, medical illness and suicidal behavior. Int J Adolesc Med Health. 2013; 25(3):279-82.
Rice TR, Dobry Y, Novakovic V, Appel JM. The importance of patient-provider communication in end-of-life care. J Bioeth Inq. 2012 Dec; 9(4):439-41.
Dobry Y, Sher L. Stimulant substitution in methamphetamine dependence. Aust N Z J Psychiatry. 2012 Dec; 46(12):1201-2.
Dobry Y, Sher L. Post-traumatic stress disorder, associated medical illnesses, and suicidal behavior: plenty of room for new research. Aust N Z J Psychiatry. 2012; 46(7):684.
Li H, Foss SM, Dobry Y, Park CK, Hires SA, Shaner NC, Tsien RY, Osborne LC, Voglmaier SM. Concurrent imaging of synaptic vesicle recycling and calcium dynamics. Front Mol Neurosci. 2011; 4:34.
Li H, Waites CL, Staal RG, Dobry Y, Park J, Sulzer DL, Edwards RH. Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines. Neuron. 2005; 48(4):619-33.
Anne Germain, Thomas C. Sleep and Combat-Related Post Traumatic Stress Disorder. (2017)
Suicidal behavior in Post-Traumatic Stress Disorder: Focus on Combat Exposure. (pp. 77-87). Springer. New York, New York. Dobry, M.D. and Leo Sher M.D.
Sadock B.J, Sadock A, Rulz P. (2017). In A. Editor, B. Editor, C. Editor (Eds.). Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. (pp. 3003-3019). Philadelphia, Pennsylvania. Lippincott, Williams and Wilkins, 10th edition. Central Nervous System Sympathomimetic Compounds. Manpreet K.Singh, M.D., M.S., and Yuriy Dobry, M.D.